88 related articles for article (PubMed ID: 6413579)
1. Characterization of a monoclonal antibody directed to a T cell suppressor factor.
Maier T; Stammers AT; Levy JG
J Immunol; 1983 Oct; 131(4):1843-8. PubMed ID: 6413579
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a tumor-specific T suppressor factor from a T cell hybridoma.
Steele JK; Stammers AT; Levy JG
J Immunol; 1985 Apr; 134(4):2767-78. PubMed ID: 2579156
[TBL] [Abstract][Full Text] [Related]
3. Immunization of DBA/2 mice with a T cell hybridoma-derived TsF increases immune resistance to the syngeneic tumors P815 and L1210.
Steele JK; Singhai R; Stammers AT; Levy JG
J Immunol; 1986 Nov; 137(9):3025-30. PubMed ID: 3489783
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an anti-idiotypic T cell hybridoma involved in the regulation of the immune response to the P815 mastocytoma.
Steele JK; Tench Stammers A; Chan A; Levy JG
J Immunol; 1986 Dec; 137(11):3550-6. PubMed ID: 3097127
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody raised to tumor-specific T cell-derived suppressor factors also recognizes T suppressor inducer factors of the 4-hydroxy-3-nitrophenyl acetyl hapten suppressor network.
Steele JK; Kawasaki H; Kuchroo VK; Minami M; Levy JG; Dorf ME
J Immunol; 1987 Oct; 139(8):2629-34. PubMed ID: 2443567
[TBL] [Abstract][Full Text] [Related]
6. Preliminary characterization of a soluble immunosuppressive molecule from DBA/2 spleen cells using monoclonal antibody immunoadsorbence.
Steele JK; Stammers AT; Chan A; Maier T; Levy JG
Cell Immunol; 1985 Feb; 90(2):303-13. PubMed ID: 3155655
[TBL] [Abstract][Full Text] [Related]
7. Preliminary characterization of human T cell suppressor factor (HTsF) isolated from tonsil cells by monoclonal antibody immunoadsorbence.
Steele JK; Stammers AT; Levy JG
J Immunol; 1985 Aug; 135(2):1201-6. PubMed ID: 3159788
[TBL] [Abstract][Full Text] [Related]
8. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
Takei F; Levy JG; Kilburn DG
J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
[TBL] [Abstract][Full Text] [Related]
9. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
Hashimoto N; Takatsu K; Masuho Y; Kishida K; Hara T; Hamaoka T
J Immunol; 1984 Jan; 132(1):129-35. PubMed ID: 6418795
[TBL] [Abstract][Full Text] [Related]
10. Isolation of an antigen-specific T suppressor factor that suppresses the in vivo response of DBA/2 mice to ferredoxin.
Steele JK; Chu NR; Chan A; North J; Levy JG
J Immunol; 1987 Jul; 139(2):469-75. PubMed ID: 3496382
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies specific for single chain or two chain GAT-specific suppressor factors: production and analysis of in vitro modulating properties.
Sorensen CM; Pierce CW
J Immunol; 1985 Jul; 135(1):362-7. PubMed ID: 2582038
[TBL] [Abstract][Full Text] [Related]
12. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
Takei F; Levy JG; Kilburn DG
J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
[TBL] [Abstract][Full Text] [Related]
13. Equivalence of conventional anti-picryl T suppressor factor in the contact sensitivity system and monoclonal anti-NP TsF3: their final non-specific effect via the T acceptor cell.
Asherson GL; Dorf ME; Colizzi V; Zembala M; James BM
Immunology; 1984 Nov; 53(3):491-7. PubMed ID: 6333385
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a T suppressor factor by using a monoclonal antibody.
Ferguson TA; Beaman KD; Iverson GM
J Immunol; 1985 May; 134(5):3163-71. PubMed ID: 2580016
[TBL] [Abstract][Full Text] [Related]
15. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
16. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
Fuji H
Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
[TBL] [Abstract][Full Text] [Related]
18. The role of interleukin-2 (IL-2) in the differentiatin of cytotoxic T cells: the effect of monoclonal anti-IL-2 antibody and absorption with IL-2 dependent T cell lines.
Kern DE; Gillis S; Okada M; Henney CS
J Immunol; 1981 Oct; 127(4):1323-8. PubMed ID: 6456304
[TBL] [Abstract][Full Text] [Related]
19. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
20. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
Niederkorn JY; Streilein JW
J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
